From tennis star Gabriela Dabrowski sharing details of her breast cancer journey to Greg Gumbel and Linda Lavin dying, here ...

Dr Sattva S. Neelapu discusses data from the ZUMA-5 trial investigating the CAR T-cell therapy Yescarta in relapsed/refractory follicular lymphoma.

I've learned to embrace the changing nature of my body as I age, accepting the challenges and finding gratitude in each day.

An NDA has been accepted by the FDA for the combination of avutometinib and defactinib in KRAS-mutated recurrent low-grade ...

An expert explained recent findings from a study of pregnant women with breast cancer who underwent chemotherapy and fared ...

Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma ...

One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment ...

A panelist discusses how polycythemia vera (PV) symptoms can vary significantly among patients, but commonly include headaches, dizziness, itching (especially after warm baths), fatigue and visual ...

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading ...

A patient with MPN urges others to ask questions about treatment options, which may also include inquiring about clinical ...

CURE created a list of the top breast cancer stories of this year, including those focused on patient-reported outcomes and ...

NX-5948 has received fast track designation for adults with relapsed or refractory Waldenström macroglobulinemia who received ...